Thus, we demonstrated that the regulation of Prevotella, nervonic acid, all‐trans retinoic acid, CRP, LBP, and CD14 could be an underlying therapeutic strategy for the inflammatory treatment of NSCLC. This evidence concerns the gene LBP and non-small cell lung carcinoma.